Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. 3. Formation, degradation, and reformation of cyclic adenosine 3',5'-monophosphate during sequential stimulations by biogenic amines and adenosine.
D000225:Adenine / Q000378:metabolism; D000241:Adenosine / Q000494:pharmacology*; D000818:Animals; D001679:Biogenic Amines / Q000494:pharmacology*; D002247:Carbon Isotopes; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D000242:Cyclic AMP / Q000096:biosynthesis / Q000378:metabolism*; D004357:Drug Synergism; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014702:Veratrine / Q000494:pharmacology
D001679:Biogenic Amines; D002247:Carbon Isotopes; D006634:Histamine H1 Antagonists; D010726:Phosphodiesterase Inhibitors; D014316:Tritium; D006632:Histamine; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D014702:Veratrine; D000225:Adenine; D000241:Adenosine; D009638:Norepinephrine